Replies to post #71678 on Biotech Values

[DewDiligence]

Cases Where FDA Rejected a Drug Endorsed by Advisory Panel

[Who will be next? Note: this table
does not purport to be exhaustive.]

 
                        Panel Vote    Date of    iHub 
 Company    Drug       For Approval  FDA Action  Reference 
 PFE     Lasofoxifene      9-3          1/09     #msg-34890112 
 Roche   Actemra          10-1         12/08     #msg-33965815 
 SGP     Sugammadex       14-0          8/08     #msg-31141155 
 DNDN    Provenge         13-4          5/07     #msg-19483904

Comments are welcome about additions or alterations to the table.

[ghmm]

Lasofoxifene:

Just to update this a little bit. I am reviewing some LGND stuff (they get a 3% royalty on all sales they had a 6% royalty but sold 3% to royalty pharma) and according to their 10K Pfizer is looking to outlicense this its approved in the EU (2/09) and according to LGND its not expected to be launched there at least in 2010.